Table 2.
According to 1 mm tumor clearance (main study definition) | ||||
---|---|---|---|---|
Univariable analysis | P-value | Multivariable analysisa | P-value | |
OR (95% CI) | OR (95% CI) | |||
Age | 0.99 (0.98–0.99) | 0.003 | 0.99 (0.98–0.99) | 0.008 |
Female | 1.04 (0.89–1.20) | 0.604 | ||
Neoadjuvant chemo(radio)therapy | 1.29 (0.98–1.71) | 0.075 | ||
T stageb | ||||
1 | Reference | Reference | ||
2 | 0.37 (0.27–0.48) | < 0.001 | 0.49 (0.37–0.64) | < 0.001 |
3 | 0.36 (0.28–0.47) | < 0.001 | 0.35 (0.26–0.47) | < 0.001 |
4 | 0.19 (0.13–0.29) | < 0.001 | 0.23 (0.14–0.35) | < 0.001 |
LNR | 0.22 (0.15–0.31) | < 0.001 | 0.29 (0.20–0.42) | < 0.001 |
PD performed in high-volume center (≥ 40 PD/year) | 0.87 (0.76–1.01) | 0.077 | ||
Completeness of pathology reportc | 0.77 (0.70–0.84) | < 0.001 | 0.76 (0.69–0.83) | < 0.001 |
Bold numbers in univariable analysis indicate variables that were entered in multivariable analysis. Bold numbers in multivariable analysis indicate statistical significance (P < 0.05). OR odds ratio, LNR lymph node ratio, PD pancreatoduodenectomy
aMultivariable analysis after backward step selection in 2876 patients (62 deleted due to missing values)
bif pT stage was unavailable, cT stage was used
cscore between 0–6 based on the following variables: histological diagnosis, origin of the tumor, resection margin, extent of invasion, LNR, and tumor size